Robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for as much as 10 years, says a study.
Using several standard measures of cancer-treatment success, researchers found that 98.8% of the patients survived cancer for 10 years after their surgery.
The results are comparable to the more invasive open surgery to remove the entire diseased prostate and surrounding tissue.
"Until our analysis, there was little available information on the long-term oncologic outcomes for patients who undergo robot-assisted radical prostatectomy, or RARP," said Mireya Diaz, form Vattikuti Urology Institute, Henry Ford Health System in the US.
The researchers studied 483 men who had prostate cancer and received robot assisted surgery from 2001 to 2003.
The study was published in the journal European Urology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)